{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T10:12:37Z","timestamp":1778839957755,"version":"3.51.4"},"reference-count":45,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,5,6]],"date-time":"2027-05-06T00:00:00Z","timestamp":1809561600000},"content-version":"am","delay-in-days":370,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100007313","name":"University of Texas MD Anderson Cancer Center","doi-asserted-by":"publisher","award":["P30 CA016672"],"award-info":[{"award-number":["P30 CA016672"]}],"id":[{"id":"10.13039\/100007313","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007313","name":"University of Texas MD Anderson Cancer Center","doi-asserted-by":"publisher","award":["P50 CA142509"],"award-info":[{"award-number":["P50 CA142509"]}],"id":[{"id":"10.13039\/100007313","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012287","name":"Andrew Sabin Family Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012287","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Institutes of Health National Cancer Institute","doi-asserted-by":"publisher","award":["P30 CA016672"],"award-info":[{"award-number":["P30 CA016672"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinical-lymphoma-myeloma-leukemia.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lymphoma Myeloma and Leukemia"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.clml.2026.01.014","type":"journal-article","created":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T15:51:54Z","timestamp":1769874714000},"page":"e611-e618.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Analysis of Social Drivers of Health, Race, and Ethnicity With Survival in Myeloma Patients"],"prefix":"10.1016","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7218-9960","authenticated-orcid":false,"given":"Christen M.","family":"Dillard","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashwath","family":"Gurumurthi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans C.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8596-7058","authenticated-orcid":false,"given":"Sheeba K.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donna M.","family":"Weber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert Z.","family":"Orlowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muzaffar H.","family":"Qazilbash","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krina K.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle A.T.","family":"Hildebrandt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"22","key":"10.1016\/j.clml.2026.01.014_bib0001","doi-asserted-by":"crossref","first-page":"5419","DOI":"10.1158\/1078-0432.CCR-16-0625","article-title":"Progress and paradigms in multiple myeloma","volume":"22","author":"Anderson","year":"2016","journal-title":"Clin Cancer Res"},{"issue":"5","key":"10.1016\/j.clml.2026.01.014_bib0002","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1038\/leu.2013.313","article-title":"Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patients","volume":"28","author":"Kumar","year":"2014","journal-title":"Leukemia"},{"issue":"2","key":"10.1016\/j.clml.2026.01.014_bib0003","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1182\/bloodadvances.2017010512","article-title":"Survival of ethnic and racial minority patients with multiple myeloma treated with newer medications","volume":"2","author":"Pulte","year":"2018","journal-title":"Blood Adv"},{"issue":"4","key":"10.1016\/j.clml.2026.01.014_bib0004","doi-asserted-by":"crossref","first-page":"e384","DOI":"10.1016\/j.clml.2020.11.013","article-title":"Multiple myeloma in Hispanics: incidence, characteristics, survival, results of discovery, and validation using real-world and connect MM registry data","volume":"21","author":"Kaur","year":"2021","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"1","key":"10.1016\/j.clml.2026.01.014_bib0005","first-page":"17","article-title":"Cancer statistics, 2023","volume":"73","author":"Siegel","year":"2023","journal-title":"CA Cancer J Clin"},{"issue":"12","key":"10.1016\/j.clml.2026.01.014_bib0006","doi-asserted-by":"crossref","first-page":"E455","DOI":"10.1002\/ajh.26360","article-title":"Black multiple myeloma patients undergoing upfront autologous stem cell transplant have similar survival outcomes compared to Whites: a propensity-score matched analysis","volume":"96","author":"Patel","year":"2021","journal-title":"Am J Hematol"},{"issue":"2","key":"10.1016\/j.clml.2026.01.014_bib0007","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1111\/bjh.13950","article-title":"Race-based differences in routine cytogenetic profiles of patients with multiple myeloma","volume":"176","author":"Blue","year":"2017","journal-title":"Br J Haematol"},{"issue":"24","key":"10.1016\/j.clml.2026.01.014_bib0008","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1182\/blood.2019000406","article-title":"With equal access, African American patients have superior survival compared to White patients with multiple myeloma: a VA study","volume":"133","author":"Munjuluri","year":"2019","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.clml.2026.01.014_bib0009","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/s41408-022-00633-5","article-title":"Black patients with multiple myeloma have better survival than White patients when treated equally: a matched cohort study","volume":"12","author":"Dong","year":"2022","journal-title":"Blood Cancer J"},{"issue":"4","key":"10.1016\/j.clml.2026.01.014_bib0010","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.bbmt.2014.12.024","article-title":"Disparities in utilization of autologous hematopoietic cell transplantation for treatment of multiple myeloma","volume":"21","author":"Costa","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.clml.2026.01.014_bib0011","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1200\/EDBK_238551","article-title":"Many shades of disparities in myeloma care","volume":"39","author":"Ganguly","year":"2019","journal-title":"Am Soc Clin Oncol Educ Book"},{"issue":"8","key":"10.1016\/j.clml.2026.01.014_bib0012","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1002\/ajh.23753","article-title":"Use of autologous hematopoietic cell transplantation as initial therapy in multiple myeloma and the impact of socio-geo-demographic factors in the era of novel agents","volume":"89","author":"Al-Hamadani","year":"2014","journal-title":"Am J Hematol"},{"issue":"9","key":"10.1016\/j.clml.2026.01.014_bib0013","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1002\/cncr.30526","article-title":"Racial disparities in treatment use for multiple myeloma","volume":"123","author":"Fiala","year":"2017","journal-title":"Cancer"},{"issue":"16_suppl","key":"10.1016\/j.clml.2026.01.014_bib0014","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1200\/JCO.2024.42.16_suppl.1583","article-title":"Association between social determinants of health and time to treatment for newly diagnosed multiple myeloma","volume":"42","author":"Gasoyan","year":"2024","journal-title":"J Clin Oncol"},{"issue":"20","key":"10.1016\/j.clml.2026.01.014_bib0015","doi-asserted-by":"crossref","first-page":"2986","DOI":"10.1182\/bloodadvances.2019000308","article-title":"Racial disparities in treatment patterns and outcomes among patients with multiple myeloma: a SEER-Medicare Analysis","volume":"3","author":"Ailawadhi","year":"2019","journal-title":"Blood Adv"},{"issue":"5","key":"10.1016\/j.clml.2026.01.014_bib0016","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.3109\/10428194.2013.827188","article-title":"Recent improvement in survival of patients with multiple myeloma: variation by ethnicity","volume":"55","author":"Pulte","year":"2014","journal-title":"Leuk Lymphoma"},{"issue":"10","key":"10.1016\/j.clml.2026.01.014_bib0017","doi-asserted-by":"crossref","first-page":"e408","DOI":"10.1016\/S2352-3026(15)00151-9","article-title":"Financial toxicity in insured patients with multiple myeloma: a cross-sectional pilot study","volume":"2","author":"Huntington","year":"2015","journal-title":"Lancet Haematol"},{"issue":"16_suppl","key":"10.1016\/j.clml.2026.01.014_bib0018","doi-asserted-by":"crossref","first-page":"6602","DOI":"10.1200\/JCO.2022.40.16_suppl.6602","article-title":"Self-reported financial difficulties among patients with multiple myeloma and chronic lymphocytic leukemia: an Alliance for Clinical Trials in Oncology Study","volume":"40","author":"Conti","year":"2022","journal-title":"J Clin Oncol"},{"issue":"10","key":"10.1016\/j.clml.2026.01.014_bib0019","doi-asserted-by":"crossref","first-page":"5727","DOI":"10.21873\/anticanres.14587","article-title":"Impact of the Affordable Care Act on timeliness to treatment for patients with multiple myeloma","volume":"40","author":"Jayakrishnan","year":"2020","journal-title":"Anticancer Res"},{"issue":"10","key":"10.1016\/j.clml.2026.01.014_bib0020","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1080\/10428194.2020.1767290","article-title":"Treatment disparities in minority groups with multiple myeloma at a safety-net hospital","volume":"61","author":"Dennis","year":"2020","journal-title":"Leuk Lymphoma"},{"issue":"20","key":"10.1016\/j.clml.2026.01.014_bib0021","doi-asserted-by":"crossref","first-page":"3183","DOI":"10.1002\/cncr.30183","article-title":"Impact of marital status, insurance status, income, and race\/ethnicity on the survival of younger patients diagnosed with multiple myeloma in the United States","volume":"122","author":"Costa","year":"2016","journal-title":"Cancer"},{"issue":"16","key":"10.1016\/j.clml.2026.01.014_bib0022","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.3390\/healthcare12161587","article-title":"Patient perspectives on social and identity factors affecting multiple myeloma care: barriers and opportunities","volume":"12","author":"Neparidze","year":"2024","journal-title":"Healthcare (Basel)"},{"issue":"2","key":"10.1016\/j.clml.2026.01.014_bib0023","doi-asserted-by":"crossref","DOI":"10.1016\/j.jgo.2022.12.003","article-title":"Association of individual low-income status and area deprivation with mortality in multiple myeloma","volume":"14","author":"Hong","year":"2023","journal-title":"J Geriatr Oncol"},{"issue":"9","key":"10.1016\/j.clml.2026.01.014_bib0024","first-page":"1021","article-title":"Differences in survival among multiple myeloma patients in the United States SEER population by neighborhood socioeconomic status and race\/ethnicity","volume":"32","author":"Casta\u00f1eda-Avila","year":"2021","journal-title":"Cancer Causes Control"},{"issue":"5","key":"10.1016\/j.clml.2026.01.014_bib0025","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/s41408-022-00681-x","article-title":"Socioeconomic disadvantage contributes to ethnic disparities in multiple myeloma survival: a matched cohort study","volume":"12","author":"Buradagunta","year":"2022","journal-title":"Blood Cancer J"},{"issue":"4","key":"10.1016\/j.clml.2026.01.014_bib0026","doi-asserted-by":"crossref","first-page":"797","DOI":"10.3390\/cancers13040590","article-title":"Socioeconomic factors and survival of multiple myeloma patients","volume":"13","author":"Chamoun","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"26","key":"10.1016\/j.clml.2026.01.014_bib0027","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.1200\/JCO.2015.61.2267","article-title":"Revised International Staging System for multiple myeloma: a report from International Myeloma Working Group","volume":"33","author":"Palumbo","year":"2015","journal-title":"J Clin Oncol"},{"issue":"15","key":"10.1016\/j.clml.2026.01.014_bib0028","doi-asserted-by":"crossref","first-page":"3412","DOI":"10.1200\/JCO.2005.04.242","article-title":"International staging system for multiple myeloma","volume":"23","author":"Greipp","year":"2005","journal-title":"J Clin Oncol"},{"issue":"10","key":"10.1016\/j.clml.2026.01.014_bib0029","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1002\/ajh.23810","article-title":"Multiple myeloma: 2014 update on diagnosis, risk stratification, and management","volume":"89","author":"Rajkumar","year":"2014","journal-title":"Am J Hematol"},{"issue":"26","key":"10.1016\/j.clml.2026.01.014_bib0030","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1056\/NEJMp1802313","article-title":"Making neighborhood-disadvantage metrics accessible\u2014the neighborhood atlas","volume":"378","author":"Kind","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clml.2026.01.014_bib0031","unstructured":"University of Wisconsin School of Medicine and Public Health. 2019 area deprivation index v3.1. Accessed May 28, 2021. https:\/\/www.neighborhoodatlas.medicine.wisc.edu."},{"key":"10.1016\/j.clml.2026.01.014_bib0032","series-title":"Stata: Release 17. Statistical Software","year":"2021"},{"issue":"4","key":"10.1016\/j.clml.2026.01.014_bib0033","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/s41409-024-02200-x","article-title":"The impact of social vulnerability index on survival following autologous stem cell transplant for multiple myeloma","volume":"59","author":"Salafian","year":"2024","journal-title":"Bone Marrow Transplant"},{"issue":"3","key":"10.1016\/j.clml.2026.01.014_bib0034","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.clml.2020.11.020","article-title":"Impact of socioeconomic characteristics and comorbidities on therapy initiation and outcomes of newly diagnosed multiple myeloma: real-world data from a resource-constrained setting","volume":"21","author":"Vargas-Serafin","year":"2021","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"7","key":"10.1016\/j.clml.2026.01.014_bib0035","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/s41408-018-0102-7","article-title":"Disease and outcome disparities in multiple myeloma: exploring the role of race\/ethnicity in the cooperative group clinical trials","volume":"8","author":"Ailawadhi","year":"2018","journal-title":"Blood Cancer J"},{"issue":"Suppl 1","key":"10.1016\/j.clml.2026.01.014_bib0036","doi-asserted-by":"crossref","first-page":"5155","DOI":"10.1182\/blood-2024-211737","article-title":"Characterization and comparative outcomes of younger multiple myeloma patients","volume":"144","author":"Tufano-Sugarman","year":"2024","journal-title":"Blood"},{"issue":"25","key":"10.1016\/j.clml.2026.01.014_bib0037","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1182\/blood.2021013539","article-title":"Diagnosed with myeloma before age 40","volume":"138","author":"Landgren","year":"2021","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.clml.2026.01.014_bib0038","doi-asserted-by":"crossref","first-page":"5214","DOI":"10.3390\/curroncol30060396","article-title":"Young myeloma patients: a systematic review of manifestations and outcomes","volume":"30","author":"Tanguay","year":"2023","journal-title":"Curr Oncol"},{"issue":"10","key":"10.1016\/j.clml.2026.01.014_bib0039","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/s41408-018-0132-1","article-title":"Differences in genomic abnormalities among African individuals with monoclonal gammopathies using calculated ancestry","volume":"8","author":"Baughn","year":"2018","journal-title":"Blood Cancer J"},{"issue":"7","key":"10.1016\/j.clml.2026.01.014_bib0040","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1038\/leu.2014.34","article-title":"Racial disparities in the prevalence of monoclonal gammopathies: a population-based study of 12,482 persons from the National Health and Nutritional Examination Survey","volume":"28","author":"Landgren","year":"2014","journal-title":"Leukemia"},{"issue":"8","key":"10.1016\/j.clml.2026.01.014_bib0041","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/s41408-020-00348-5","article-title":"Cytogenetic abnormalities in multiple myeloma: association with disease characteristics and treatment response","volume":"10","author":"Abdallah","year":"2020","journal-title":"Blood Cancer J"},{"issue":"8","key":"10.1016\/j.clml.2026.01.014_bib0042","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/s41408-020-00347-6","article-title":"Racial differences in treatment and outcomes in multiple myeloma: a multiple myeloma research foundation analysis","volume":"10","author":"Derman","year":"2020","journal-title":"Blood Cancer J"},{"issue":"1","key":"10.1016\/j.clml.2026.01.014_bib0043","doi-asserted-by":"crossref","first-page":"e271","DOI":"10.1038\/bcj.2014.91","article-title":"Racial differences in primary cytogenetic abnormalities in multiple myeloma: a multi-center study","volume":"5","author":"Greenberg","year":"2015","journal-title":"Blood Cancer J"},{"issue":"1","key":"10.1016\/j.clml.2026.01.014_bib0044","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1182\/bloodadvances.2023010894","article-title":"Racial and ethnic differences in clinical outcomes among patients with multiple myeloma treated with CAR T-cell therapy","volume":"8","author":"Peres","year":"2024","journal-title":"Blood Adv"},{"issue":"2","key":"10.1016\/j.clml.2026.01.014_bib0045","doi-asserted-by":"crossref","first-page":"S322","DOI":"10.1016\/j.jtct.2023.12.446","article-title":"Idecabtagene vicleucel (ide-cel) versus standard regimens in triple-class\u2013exposed relapsed and refractory multiple myeloma: karMMa-3 subanalysis of black patients","volume":"30","author":"Patel","year":"2024","journal-title":"Transplant Cell Ther"}],"container-title":["Clinical Lymphoma Myeloma and Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265026000297?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265026000297?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T09:50:05Z","timestamp":1778838605000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2152265026000297"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":45,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S2152265026000297"],"URL":"https:\/\/doi.org\/10.1016\/j.clml.2026.01.014","relation":{},"ISSN":["2152-2650"],"issn-type":[{"value":"2152-2650","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Analysis of Social Drivers of Health, Race, and Ethnicity With Survival in Myeloma Patients","name":"articletitle","label":"Article Title"},{"value":"Clinical Lymphoma Myeloma and Leukemia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clml.2026.01.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}